As depicted in Fig. S3A, OXI treatment suppressed the activation of Akt/mTOR axis in CRC cells, as demonstrated by reduced phosphorylation level of Akt and mTOR, as well as the downstream effector 4E-BP1 and p70S6K. This evidence concerns the gene MTOR and colorectal carcinoma.